Tag Archives: VAL

Best Clean Energy Stocks To Watch For 2019

Clean energy stocks in 2018 are on the cusp of massive growth, as the sector is projected to expand by 500% in the United States alone…

The Energy Information Agency is projecting renewable energy production to grow 500% by 2040.

The World’s First “Universal Fuel”: Physicists have known about an unlimited source of free fuel for over 100 years. See why tech companies are investing millions in this fuel (and how to join them). Click here…

And that means right now is the time to invest in clean energy stocks before they begin to soar.

To help Money Morning readers profit from the massive industry growth ahead, we’re giving our readers one of the best clean energy stocks to buy right now. More on that pick in just a bit, but we want to first show you why the renewable energy sector is set to soar…

How Renewables Will Power Clean Energy Stocks in 2018

There are three major catalysts propelling alternative energy sources to explosive growth potential. And as the sector grows, so will renewable energy stocks…

Best Clean Energy Stocks To Watch For 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Bloomin’ Brands (NASDAQ:BLMN) from a hold rating to a sell rating in a research note issued to investors on Tuesday.

  • [By Joseph Griffin]

    Bloomin’ Brands (NASDAQ: BLMN) and Brinker International (NYSE:EAT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

  • [By Joseph Griffin]

    Equities research analysts expect Bloomin’ Brands Inc (NASDAQ:BLMN) to report earnings per share of $0.08 for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for Bloomin’ Brands’ earnings. The highest EPS estimate is $0.12 and the lowest is $0.05. Bloomin’ Brands reported earnings of $0.12 per share during the same quarter last year, which indicates a negative year over year growth rate of 33.3%. The business is scheduled to issue its next earnings report on Friday, November 2nd.

  • [By Sean Williams]

    The casual-dining restaurant stock I’d most suggest avoiding in this industry is Bloomin’ Brands (NASDAQ:BLMN), the parent of Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s Steakhouse.

Best Clean Energy Stocks To Watch For 2019: Valspar Corporation (VAL)

Advisors’ Opinion:

  • [By Max Byerly]

    Valorbit (CURRENCY:VAL) traded 0% higher against the dollar during the 1 day period ending at 11:00 AM Eastern on June 9th. One Valorbit coin can currently be bought for approximately $0.0001 or 0.00000001 BTC on exchanges. Valorbit has a market cap of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last 24 hours. In the last seven days, Valorbit has traded up 5.8% against the dollar.

  • [By Shane Hupp]

    Shares of ValiRx Plc (LON:VAL) rose 5.6% during mid-day trading on Thursday . The company traded as high as GBX 1.90 ($0.02) and last traded at GBX 1.90 ($0.02). Approximately 587,748 shares were traded during trading, a decline of 85% from the average daily volume of 3,820,000 shares. The stock had previously closed at GBX 1.80 ($0.02).

  • [By Stephan Byrd]

    Valorbit (CURRENCY:VAL) traded up 0% against the U.S. dollar during the 1 day period ending at 0:00 AM E.T. on June 18th. One Valorbit coin can now be bought for approximately $0.0001 or 0.00000001 BTC on popular exchanges. Valorbit has a total market capitalization of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last day. During the last week, Valorbit has traded 5.8% higher against the U.S. dollar.

Best Clean Energy Stocks To Watch For 2019: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod (finance.yahoo.com) Merrimack Fails Phase 2 Pancreatic Cancer Study, But Opportunity Remains (seekingalpha.com) Merrimack Pharmaceuticals’ (MACK) “Hold” Rating Reaffirmed at Robert W. Baird (americanbankingnews.com) Merrimack Crashes as Phase II Pancreatic Cancer Study Fails (zacks.com) MM-141 (benzinga.com)

    Several equities analysts have commented on MACK shares. Zacks Investment Research raised Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a research report on Wednesday, April 25th. JPMorgan Chase & Co. downgraded Merrimack Pharmaceuticals from a “neutral” rating to an “underweight” rating in a research report on Monday. Robert W. Baird cut their price objective on Merrimack Pharmaceuticals from $12.00 to $7.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, ValuEngine raised Merrimack Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Tuesday.

  • [By Chris Lange]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) shares were absolutely crushed on Monday after the firm gave an update from its midstage pancreatic cancer study. Specifically, the top-line results come from the CARRIE study, a randomized Phase 2 trial evaluating the addition of MM-141 (istiratumab) to standard-of-care treatment in patients with previously untreated metastatic pancreatic cancer.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

Best Clean Energy Stocks To Watch For 2019: Timken Company (TKR)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine downgraded shares of Timken (NYSE:TKR) from a sell rating to a strong sell rating in a research report sent to investors on Monday.

    A number of other research firms have also recently commented on TKR. Bank of America increased their target price on Timken from $50.00 to $51.00 and gave the company an underperform rating in a research note on Tuesday, May 22nd. Stifel Nicolaus upgraded shares of Timken from a hold rating to a buy rating and upped their price target for the company from $52.00 to $60.00 in a research report on Monday, May 28th. Zacks Investment Research lowered shares of Timken from a buy rating to a hold rating in a research report on Wednesday, March 21st. Vertical Research upgraded shares of Timken from a hold rating to a buy rating in a research report on Friday, May 4th. Finally, CL King began coverage on shares of Timken in a research report on Thursday, June 28th. They set a neutral rating for the company. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and seven have assigned a buy rating to the stock. Timken currently has a consensus rating of Hold and an average target price of $52.83.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Timken (TKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    CryptoInsight (CURRENCY:TKR) traded flat against the dollar during the 24 hour period ending at 21:00 PM Eastern on September 11th. One CryptoInsight token can now be purchased for about $0.0040 or 0.00000063 BTC on major exchanges including HitBTC and IDEX. Over the last week, CryptoInsight has traded down 15.8% against the dollar. CryptoInsight has a market cap of $49,784.00 and $0.00 worth of CryptoInsight was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    Bank of Montreal Can acquired a new position in shares of Timken Co (NYSE:TKR) during the second quarter, HoldingsChannel reports. The firm acquired 2,822 shares of the industrial products company’s stock, valued at approximately $123,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Timken (TKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Performing Stocks To Invest In Right Now

Advanced Micro Devices, Inc is scheduled to preview its Vega GPUs today at GDC. Vega GPUs are expected to be another tailwind for AMD stock.
Flickr

For the past one year, Advanced Micro Devices, Inc. (NASDAQ:AMD) stock has been one of the best performing stocks on the NASDAQ. AMD stock has gained by a massive 600% in the last one year. The stock is up 38% this year. While hype and speculation have played a part in this rally (as they do in any stock rallies), improving fundamentals were the major force behind the rally. Last year, AMD stock was trading at a PS of 0.3, as the risk of bankruptcy loomed large. But, with the risk of collapse taking a backseat, AMD’s valuation has improved, propelling its stock price higher.

Top 5 Performing Stocks To Invest In Right Now: Valspar Corporation (VAL)

Advisors’ Opinion:

  • [By Max Byerly]

    Valorbit (CURRENCY:VAL) traded 0% higher against the dollar during the 1 day period ending at 11:00 AM Eastern on June 9th. One Valorbit coin can currently be bought for approximately $0.0001 or 0.00000001 BTC on exchanges. Valorbit has a market cap of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last 24 hours. In the last seven days, Valorbit has traded up 5.8% against the dollar.

  • [By Shane Hupp]

    Shares of ValiRx Plc (LON:VAL) rose 5.6% during mid-day trading on Thursday . The company traded as high as GBX 1.90 ($0.02) and last traded at GBX 1.90 ($0.02). Approximately 587,748 shares were traded during trading, a decline of 85% from the average daily volume of 3,820,000 shares. The stock had previously closed at GBX 1.80 ($0.02).

  • [By Stephan Byrd]

    Valorbit (CURRENCY:VAL) traded up 0% against the U.S. dollar during the 1 day period ending at 0:00 AM E.T. on June 18th. One Valorbit coin can now be bought for approximately $0.0001 or 0.00000001 BTC on popular exchanges. Valorbit has a total market capitalization of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last day. During the last week, Valorbit has traded 5.8% higher against the U.S. dollar.

Top 5 Performing Stocks To Invest In Right Now: Tortoise MLP Fund, Inc.(NTG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Northgate plc (LON:NTG) have received an average rating of “Buy” from the six brokerages that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is GBX 523.25 ($6.67).

Top 5 Performing Stocks To Invest In Right Now: Coherent, Inc.(COHR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Earnest Partners LLC lifted its stake in shares of Coherent, Inc. (NASDAQ:COHR) by 2.2% during the 1st quarter, Holdings Channel reports. The firm owned 453,873 shares of the scientific and technical instruments company’s stock after buying an additional 9,868 shares during the quarter. Earnest Partners LLC’s holdings in Coherent were worth $85,056,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Coherent (NASDAQ: COHR) and Integra Lifesciences (NASDAQ:IART) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation.

  • [By ]

    Coherent, Inc. (NASDAQ:COHR) is one of the oldest companies in the laser technology space based in California, US. The company employs around 5,218 employees and has grown rapidly in terms of revenues as well as profits over the past few years. A recent sell-off as a result of forex risks and a negative market sentiment with respect to lasers has brought the stock price down to reasonable valuations. However, analysts continue to remain bullish on the stock with target prices showing a minimum appreciation of 40% over the current market price.

  • [By Logan Wallace]

    Benchmark restated their buy rating on shares of Coherent (NASDAQ:COHR) in a research note published on Thursday morning. The firm currently has a $216.00 price objective on the scientific and technical instruments company’s stock.

Top 5 Performing Stocks To Invest In Right Now: Mercantile Bank Corporation(MBWM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Capstar Financial (NASDAQ: CSTR) and Mercantile Bank (NASDAQ:MBWM) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.

  • [By Stephan Byrd]

    Shares of Mercantile Bank Co. (NASDAQ:MBWM) have been given a consensus recommendation of “Hold” by the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $36.33.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Mercantile Bank (MBWM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Mercantile Bank (NASDAQ:MBWM) will issue its quarterly earnings data before the market opens on Tuesday, October 16th. Analysts expect the company to announce earnings of $0.61 per share for the quarter.

Top 5 Performing Stocks To Invest In Right Now: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Investment analysts at Roth Capital assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) in a research note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating and a $8.00 price target on the biotechnology company’s stock. Roth Capital’s price objective would suggest a potential upside of 459.44% from the company’s current price.

The 10 Best Stocks to Buy for the Next Decade

Last year, InvestorPlace contributor Dan Burrows highlighted the 10 best-performing S&P 500 stocks of the past decade. The most important lesson one finds studying these high-flying stocks is that patience wins out over all other attributes of a successful investor.

A classic example of how true this is involves the Fidelity Magellan Fund (MUTF:FMAGX), the large mutual fund made famous by portfolio manager Peter Lynch. Lynch ran the fund for 13 years from 1977 until 1990, growing it from $20 million to $14 billion before stepping aside.

Fidelity studied the returns of Fidelity Magellan unitholders over those 13 years to see how they did compared to the legendary portfolio manager. While Lynch managed to achieve a 29% annual return over this period, the average investor lost money.

Patience would have served those investors well, as the ups and downs of the stock market shook them out of their positions — and in doing so, deprived them of millions of dollars in profits. A $10,000 investment in 1977 held until 1990 was worth $273,947 by the end of that 13-year period.

I’m not Peter Lynch, but I can say with some confidence that the examples to follow are the 10 best stocks to buy for the next decade.

Let’s take a look.

Best Stocks to Buy for the Next Decade: Amazon (AMZN) Best Stocks to Buy for the Next Decade: Amazon (AMZN)investorplace.com/wp-content/uploads/2016/11/amznmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/11/amznmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/11/amznmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/11/amznmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/11/amznmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2016/11/amznmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2016/11/amznmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/11/amznmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/11/amznmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2016/11/amznmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Via Amazon

Not only is Amazon.com, Inc. (NASDAQ:AMZN) CEO and founder Jeff Bezos a great chief executive, but Amazon has its hands in so many pies — including a very profitable cloud business that generates almost $1 billion in annual operating income — that it’s hard to fathom just how big Amazon could be a decade from now.

While Amazon’s AWS cloud business is a big deal, Amazon Prime is the service that delivers the goods when it comes to building the foundation for AMZN stock. More than 100 million people subscribe to Amazon Prime at $99 per year.

It’s not the $9.9 billion in annual subscription revenue that matters, but the amount each of those subscribers spends on other Amazon products. Statistics show that 76% of Amazon Prime members spend more than they did before paying the annual $99 fee.

That’s what you call “pulling power,” and it’s a big reason why AMZN stock will be a winner for the long haul.

Best Stocks to Buy for the Next Decade: Blue Buffalo Pet Products (BUFF) Best Stocks to Buy for the Next Decade: Blue Buffalo Pet Products (BUFF)investorplace.com/wp-content/uploads/2017/07/buffmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/07/buffmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/07/buffmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/07/buffmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/07/buffmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/07/buffmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/07/buffmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/07/buffmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/07/buffmsn-78×43.jpg78w, investorplace.com/wp-content/uploads/2017/07/buffmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

If you bought Blue Buffalo Pet Products Inc (NASDAQ:BUFF) at its July 2015 IPO price of $20 and you’re still holding it, you’ve made money — barely.

The pet food maker has been on a wild ride since going public almost two years ago. It opened with a first-day return of 36%, but proceeded to fall from $28 to $16 in the span of a couple months, only to gain most of that back by its one-year anniversary.

However, BUFF is an explosive stock lying in wait.

Blue Buffalo is investing $150 million-$170 million in 2017 to expand its manufacturing capacity so that it can accommodate further growth beyond 6% of the $28 billion U.S. pet food market.

In 2016, its adjusted earnings-per-share increased 27.2% to 79 cents; it expects that number to increase by as much as 19% in 2017 to between 91 and 94 cents-per-share.

Over the past five years, Blue Buffalo has more than doubled its revenues, from $523.0 million in 2012 to $1.1 billion in 2016, while growing net income from $65.5 million to $130.2 million in the same period.

People will continue to spend more on healthy food in the coming decade, and that includes for their pets. Blue Buffalo is ready to capture more of those gains, and BUFF shareholders will benefit as a result.

Best Stocks to Buy for the Next Decade: Apple (AAPL) Best Stocks to Buy for the Next Decade: Apple (AAPL)investorplace.com/wp-content/uploads/2017/12/aaplmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/12/aaplmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/12/aaplmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/12/aaplmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/12/aaplmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/12/aaplmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/12/aaplmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/12/aaplmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/12/aaplmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/12/aaplmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

You can say what you want about the iPhone maker’s best days being behind it, but I have a feeling Apple Inc. (NASDAQ:AAPL) will continue to create products people want to buy for years to come.

What they are, I couldn’t tell you.

What I do know is that Apple will continue to generate a huge amount of free cash flow — $52.5 billion in the trailing 12 months through Dec. 31, 2016 — to reward shareholders for their patience and loyalty.

AAPL currently converts 71.7% of its EBITDA into free cash flow, which is pretty darn close to the 77.7% conversion rate of Amazon — a company known for doing a good job converting cash.

The most recent rumor on Wall Street has Apple and Walt Disney Co (NYSE:DIS) hooking up to form a media and tech conglomerate. While speculative in nature, the combination would provide Apple with a few more avenues to generate ideas for new products.

At this point, while I like Disney, I’d say it needs Apple more than Apple needs it.

Best Stocks to Buy for the Next Decade: Berkshire Hathaway (BRK.B) Best Stocks to Buy for the Next Decade: Berkshire Hathaway (BRK.B)investorplace.com/wp-content/uploads/2017/05/brkmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/05/brkmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/brkmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/brkmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/brkmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/brkmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/brkmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/brkmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/brkmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/05/brkmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Warren Buffett is 87 years old. Eventually, he’s going to step out of the game. The argument is that his departure will create a panic that will send Berkshire Hathaway Inc. (NYSE:BRK.A, NYSE:BRK.B) stock spiraling downward.

Personally, I don’t subscribe to that theory.

Businesses — whether it be a huge holding company like Buffett’s or something much less grandiose — are valued by calculating the present value of its future cash flows. Berkshire Hathaway’s are significant.

Another way is to value a business is to look at the sum of all its parts.

Berkshire Hathaway owns hundreds of businesses; each of these firms, if sold at auction, would be worth more than the current stock price would seem to reflect. If Buffett moved on and the company was broken up in a prudent manner over an extended period, Berkshire Hathaway investors would benefit greatly from such a process.

The best part of Berkshire Hathaway? You get a quasi-mutual fund with a diversified group of holdings and no management fees.

That’s the best kind of buy-and-hold investment.

Best Stocks to Buy for the Next Decade: Ulta Beauty (ULTA)

 

Best Stocks to Buy for the Next Decade: Ulta Beauty (ULTA)investorplace.com/wp-content/uploads/2017/12/ultamsn-300×150.jpg 300w, investorplace.com/wp-content/uploads/2017/12/ultamsn-768×384.jpg 768w, investorplace.com/wp-content/uploads/2017/12/ultamsn-60×30.jpg 60w, investorplace.com/wp-content/uploads/2017/12/ultamsn-200×100.jpg 200w, investorplace.com/wp-content/uploads/2017/12/ultamsn-400×200.jpg 400w, investorplace.com/wp-content/uploads/2017/12/ultamsn-116×58.jpg 116w, investorplace.com/wp-content/uploads/2017/12/ultamsn-100×50.jpg 100w, investorplace.com/wp-content/uploads/2017/12/ultamsn-78×39.jpg 78w, investorplace.com/wp-content/uploads/2017/12/ultamsn-800×400.jpg 800w,https://investorplace.com/wp-content/uploads/2017/12/ultamsn-170×85.jpg 170w” sizes=”(max-width: 950px) 100vw, 950px” />Source: Shutterstock

The retail industry is in a free fall at the moment, yet Illinois-based Ulta Beauty Inc (NASDAQ:ULTA) is busy growing its network of stores — which currently number 974 — by 100 per year. It expects to build out its brick-and-mortar footprint to 1,700 stores over the next decade.

Ulta’s business model provides a shopping experience that is unique in a beauty market where no one firm controls a big chunk of market share, not even Sephora. In fact, Ulta controls just 4% of the $127 billion U.S. beauty market despite having almost $5 billion in annual revenue.

10 Under-the-Radar Stocks to Buy Now for Explosive Upside

With consumer confidence growing, Ulta stands a good chance over the next decade of bumping this number significantly higher. ULTA shares might be expensive at 30 times earnings, but that’s the price you pay to own the best.

Best Stocks to Buy for the Next Decade: Sherwin-Williams (SHW) Best Stocks to Buy for the Next Decade: Sherwin-Williams (SHW)investorplace.com/wp-content/uploads/2017/03/shwmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/03/shwmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/03/shwmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/03/shwmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/03/shwmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/03/shwmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/03/shwmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/03/shwmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/03/shwmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/03/shwmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Ulta Beauty helps women with their beauty needs; Sherwin-Williams Co (NYSE:SHW) does the same for houses and businesses around the world.

What’s the one thing real estate professionals suggest you should do when selling your home? Give it a fresh coat of paint. It’s the most cost-effective improvement you can make to bring in better offers.

Sherwin-Williams originally tried to buy Mexican paint company Comex in 2014, but it was beaten out by PPG Industries, Inc. (NYSE:PPG). More than two years later, it’s in the homestretch of closing its $11.3 billion acquisition of The Valspar Corp (NYSE:VAL), which will significantly improve its position in the coatings business outside North America.

Over the past decade, SHW has achieved a return of more than 600%, significantly greater than the S&P 500’s 82% climb in that same period.

If any stock can repeat this kind of performance over the next decade, Sherwin-Williams has to be at the top of the list.

Best Stocks to Buy for the Next Decade: Kraft Heinz (KHC) Best Stocks to Buy for the Next Decade: Kraft Heinz (KHC)investorplace.com/wp-content/uploads/2016/10/khcmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/10/khcmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/10/khcmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/10/khcmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/10/khcmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/10/khcmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/10/khcmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/10/khcmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/10/khcmsn-170×93.jpg 170w” sizes=”(max-width:728px) 100vw, 728px” />Source: Mike Mozart via Flickr

Earlier this year, the management of Kraft Heinz Co (NASDAQ:KHC) put quite the scare into the 169,000 Unilever plc (ADR) (NYSE:UL) employees with a potential $143 billion offer to buy the company. Fortunately (for employees), Unilever’s management told the Brazilians — 3G Capital and Berkshire Hathaway control KHC — to take a hike.

Kraft Heinz is going to make another acquisition, most likely this year. And when it does, the first thing the Brazilians are going to do is trim the fat. (Read this article about Tim Hortons to understand their cost-cutting ruthlessness.) That’s going to mean the loss of a lot of jobs.

While that’s terrible for the people on the receiving end of the pink slips, it’s been proven by 3G Capital time and again to significantly increase the bottom line. Shareholders definitely will win as Kraft Heinz guts PepsiCo, Inc. (NYSE:PEP) or some other vulnerable target.

I’m of two minds when it comes to 3G Capital’s blitzkrieg management style: On the one hand, people suffer greatly from these job cuts. On the other, I wonder whether those jobs should have been created in the first place.

7 Tech Stocks That Will Crush the Market for Years

If you can live with this kind of management ruthlessness, KHC is a great business to own, because people will always have to eat.

Best Stocks to Buy for the Next Decade: Five Below (FIVE) Best Stocks to Buy for the Next Decade: Five Below (FIVE)investorplace.com/wp-content/uploads/2016/04/fivemsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/04/fivemsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/fivemsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/fivemsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/fivemsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/fivemsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/fivemsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/fivemsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/fivemsn-100×55.jpg 100w,https://investorplace.com/wp-content/uploads/2016/04/fivemsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/04/fivemsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/fivemsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Mike Mozart via Flickr (Modified)

Teen discount clothing chain Five Below Inc (NASDAQ:FIVE) saw same-store sales increase by 2% in fiscal 2016. That might not seem like a lot, but when you have retailers going out of business left and right, Jim Cramer is right to rave about this stock.

In today’s retail, you either want to be in the discount or luxury businesses … but not in the deadly middle.

Five Below has a plan to grow revenues and earnings by 20% every year until 2020 and beyond. In 2016, revenues and earnings grew 20.2% and 24.5%, respectively, to $1 billion and $71.8 million respectively.

In 2017, FIVE expects to open 100 new stores, bringing the total across the country to more than 600. Five Below sees 2,000 stores open in the U.S. at some point in the future. While it seems like an ambitious goal given how many stores are closing these days, Five Below has a very talented management team led by CEO Joel Anderson, whose previous job was CEO of Walmart.com.

At prices $5 or below, Five Below delivers a concept that’s unique to teen and pre-teen customers. And it should deliver plenty of returns over the next 10 years.

Best Stocks to Buy for the Next Decade: Cracker Barrel (CBRL) Best Stocks to Buy for the Next Decade: Cracker Barrel (CBRL)investorplace.com/wp-content/uploads/2017/04/cbrlmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/04/cbrlmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/04/cbrlmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/04/cbrlmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/04/cbrlmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/04/cbrlmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/04/cbrlmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/04/cbrlmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/04/cbrlmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/04/cbrlmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Over the past decade, Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) has doubled the performance of the S&P 500 by delivering consistent results. Its return on invested capital in 2006 was 8%; today, it’s 14%, well above the restaurant industry average of 9%.

CBRL’s unique restaurant/retail concept generates approximately 80% of its revenue from its restaurants, with its retail shop the remaining 20%. The average store throws off revenue of $4.6 million. The retail business generates sales per square foot of $440 and 50% gross margins.

On April 17, Cracker Barrel opened its first store on the West Coast in Tualatin, Oregon, a suburb of Portland. It plans to open three more locations in the Portland area. Expect continued growth out west in coming years.

Cracker Barrel features a strong female presence in upper management, representing what a modern progressive American company is supposed to look like at the top. Good on them … and good for you, because that kind of diversity will pay off in spades.

Best Stocks to Buy for the Next Decade: ResMed (RMD) Best Stocks to Buy for the Next Decade: ResMed (RMD)investorplace.com/wp-content/uploads/2017/04/rmdmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/04/rmdmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/04/rmdmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/04/rmdmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/04/rmdmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/04/rmdmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/04/rmdmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/04/rmdmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/04/rmdmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/04/rmdmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Who knew that sleep apnea paid so well?

ResMed Inc. (NYSE:RMD) manufactures medical devices and provides cloud-based software applications for medical professionals to treat and manage sleep apnea and chronic obstructive pulmonary disease (COPD). Treating 2 million patients daily, ResMed has become good at reducing healthcare costs by minimizing the effects of chronic disease.

Good businesses make and save people and companies money. ResMed does both.

Over the past decade, ResMed has delivered an annual return to shareholders of 11.9%, 478 basis points greater than the S&P 500. Year-to-date, RMD is up 40% and on its way to its fourth year of gains in the past five.

According to a recent study, 26% of adults have sleep apnea — a disorder that can wreak havoc on a person’s heart, not to mention a marriage due to both partners’ lack of sleep. My dad died as a result of COPD, a disease that effects more than 200 million people worldwide and costs the healthcare system more than $50 billion per year in the U.S. alone.

ResMed has growth opportunities in Latin America, Eastern Europe and China and India — all huge markets that will keep it busy for the next decade and beyond.

Of all the stocks to buy for the next decade, ResMed is my pick for most reliable given the markets it serves.

As of this writing, Will Ashworth did not hold a position in any of the aforementioned securities.

Compare Brokers

Top Cheap Stocks To Buy Right Now

(Editors’ Note: As discussed below, TPRP is a very illiquid security).

Tower Properties (OTCPK:TPRP) is one of the cheapest companies I have been able to find and is almost completely undiscovered by the investing public. This is a company where you are getting $1 worth of real estate, cash, shares, and property management/development/construction management earning streams for about $0.35. It is run by an excellent management team that works smart and hard to grow shareholder value over time.

Tower properties is primarily a real estate ownership company. From their home page, Tower Properties owns and/or manages a portfolio of approximately 3.5 million square feet of commercial and industrial properties, including over 1,600 multi-family units in the Kansas City and St. Louis metropolitan areas. In addition, Tower has developed over one and one-half million square feet of various types of property. That is a lot of real estate for a company that has a Market Capitalization of only $61 million ($14,500 price x 4,201 shares).

Top Cheap Stocks To Buy Right Now: Valspar Corporation (The)(VAL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Chilton first bought Sherwin Williamsduring the depths of the Great Recession. Why? “Paint is a good business,” he says. “There are 134 million homes in the US. I like knowing that when I got to bed at night…there paint will be peeling.” And while Sherwin Williamshas had quite a run, there’s a good reason to buy now: Its acquisition of Valspar (VAL).

  • [By Ben Levisohn]

    UBS analyst John Roberts and team consider whether Sherwin-Williams’ (SHW) pending purchase of Valspar (VAL) is a sign of peak pain in the U.S.:

Top Cheap Stocks To Buy Right Now: Bank of Hawaii Corporation(BOH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Bank of Hawaii Corporation (NYSE: BOH) is expected to report its quarterly earnings at $0.99 per share on revenue of $149.88 million.

    Zions Bancorporation (NASDAQ: ZION) is projected to post its quarterly earnings at $0.39 per share on revenue of $576.49 million.

Top Cheap Stocks To Buy Right Now: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

us share market

Related FL Goldman Concerned Over Retail Stocks, Where To Park The Money Short Covering May Be Retail ETF's Best Hope Retail heavyweights on tap for earnings amid disruptive backdrop (Seeking Alpha)

Foot Locker, Inc. (NYSE: FL) is expected to report its first-quarter numbers on May 20, and Susquehanna expects EPS of $1.38, a penny below the Street's view. The brokerage also noted that the retailer is the least affected by Amazon.com, Inc. (NASDAQ: AMZN) within the retail sector.

us share market: Cresud S.A.C.I.F. y A.(CRESY)

Advisors’ Opinion:

  • [By Cameron Swinehart]

    Cresud (CRESY) –

    An Argentinean based agriculture company that currently owns roughly 2.4 million acres of farmland in Argentina, Brazil, Paraguay and Bolivia. CRESY produces a variety of crops consisting of soybeans, corn, and sugarcane. It also has operations in beef cattle and milk production. In the second quarter, Cresud sold 4 of its farms for roughly $60.5 million and saw large gains in its farmland development business. CRESY is currently trading down roughly 60% from its highs back in late 2010. Many farming companies have struggled to release value for shareholders with the drop in crop prices but now many are beginning to see value with the sale of farmland.

us share market: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

us share market: Taiwan Semiconductor Manufacturing Company Ltd.(TSM)

Advisors’ Opinion:

  • [By Ashraf Eassa]

    To illustrate my point, Intel’s chief competitor, Taiwan Semiconductor Manufacturing Company (NYSE:TSM), has said that its 7-nanometer technology, which should go into mass production in the first half of 2018, delivers a roughly 1.63-fold density improvement over its 10-nanometer technology.

  • [By Ashraf Eassa]

    Contract-chip manufacturing giant Taiwan Semiconductor Manufacturing Company (NYSE:TSM) recently announced its earnings results, provided forward guidance for the current quarter, and provided a lot of insight on the ramp-up of its next-generation chip-manufacturing technology, called 10-nanometers (10nm for short).

  • [By Ashraf Eassa]

    As part of this discussion, he took the time to explain how the technology that Intel calls 14 nanometers is more like what its competitors — Samsung (NASDAQOTH:SSNLF) and Taiwan Semiconductor Manufacturing Co.(NYSE:TSM) — call 10 nanometers (smaller is generally believed to be better).

  • [By Ashraf Eassa]

    For many years, NVIDIA (NASDAQ:NVDA) has relied on Taiwan Semiconductor Manufacturing Company (NYSE:TSM) to manufacture the graphics chips it designs. Today, most of NVIDIA’s Pascal architecture-based graphics processors — from the GeForce GTX 1060, designed for mainstream PC gamers, all the way through its cutting edge Tesla P100 datacenter accelerators — are manufactured by TSMC.

  • [By Ashraf Eassa]

    A while back, DigiTimes reported that Taiwan Semiconductor Manufacturing Company (NYSE:TSM), a major contract chip manufacturer, planned to introduce an enhanced variant of its 16nm manufacturing technology dubbed “12nm.”

us share market: CF Industries Holdings, Inc.(CF)

Advisors’ Opinion:

  • [By Lisa Levin]

    Monday afternoon, the basic materials shares surged 0.57 percent. Meanwhile, top gainers in the sector included CF Industries Holdings, Inc. (NYSE: CF), up 7 percent, and Intrepid Potash, Inc. (NYSE: IPI), up 7 percent.

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

  • [By Ben Levisohn]

    CF Industries (CF) rose to the top of the S&P 500 today, continuing strength that began earlier this month.

    Getty Images

    CF Industries gained 6.9% to $28.96 today, while the S&P 500 fell 0.2% to 2,181.90. CF Industries has gained 21% in November.

    Despite the rally, CF Industries is still down 29% this year, and as recently as Nov.3, Citigroup’s P.J. Juvekar and team were writing that the fertilizer company was “looking more like a 2008 story” after weaker-than-expected earnings. Donald Trump’s election victory, however, has jumpstarted CF Industries and prompted FBN technical analystJC OHara to list it among the top-50 stocks following Trump’s election, noting that “we want to own the stocks that were first to leave the gate…New Momentum should continue.” On Nov. 9, Barron’s Michael Kahn agreed, writing that “CF Industries does merit a look.”

    CF Industries reported net income of $700 million on sales of $4.3 billion in 2015. Its market capitalization rose to $6.8 billion today from $6.3 billion yesterday.

     

  • [By Ben Levisohn]

    CF Industries Holdings (CF) has climbed 3.3% to $30.25 after getting upgraded to Buy from Neutral at Goldman Sachs.

    Nektar Therapeutics (NKTR) has soared 21% to $18.80 after positive results from a pain-killer trial.

us share market: Valspar Corporation (The)(VAL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    UBS analyst John Roberts and team consider whether Sherwin-Williams’ (SHW) pending purchase of Valspar (VAL) is a sign of peak pain in the U.S.:

  • [By Ben Levisohn]

    Chilton first bought Sherwin Williamsduring the depths of the Great Recession. Why? “Paint is a good business,” he says. “There are 134 million homes in the US. I like knowing that when I got to bed at night…there paint will be peeling.” And while Sherwin Williamshas had quite a run, there’s a good reason to buy now: Its acquisition of Valspar (VAL).